Emodin isolated from Rheum palmatum prevents cytokine-induced β-cell damage and the development of type 1 diabetes

Journal of Functional Foods

Volumn 16, Issue , 2015, Pages 9-19

  Bae, Ui Jin ^a   Song, Mi Young ^a   Jang, Hyun Young ^a   Lim, Jung Min ^a   Lee, So Yoon ^b   Ryu, Jae Ha ^b   Park, Byung Hyun ^a  

^a Chonbuk National University Medical School   (South Korea)

^b Sookmyung Women's University   (South Korea)

Author keywords

Apoptosis; Cytokine; Diabetes; Emodin; NF B; Streptozotocin

Indexed keywords

FUNGI; MUS; RHAMNACEAE; RHEUM PALMATUM; RHEUM X HYBRIDUM;

EID: 84937545556     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2015.04.016     Document Type: Article

References (48)

1. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2014, 37:S81-S90.
2. Bae U.J., Jang H.Y., Lim J.M., Hua L., Ryu J.H., Park B.H. Polyphenols isolated from Broussonetia kazinoki prevent cytokine-induced β-cell damage and the development of type 1 diabetes. Experimental & Molecular Medicine 2015, 47:e160.
3. Bae U.J., Lee D.Y., Song M.Y., Lee S.M., Park J.W., Ryu J.H., Park B.H. A prenylated flavan from Broussonetia kazinoki prevents cytokine-induced β-cell death through suppression of nuclear factor-κB activity. Biological & Pharmaceutical Bulletin 2011, 34:1026-1031.
4. Bae U.J., Song M.Y., Jang H.Y., Gim H.J., Ryu J.H., Lee S.M., Jeon R., Park B.H. The efficacy of SPA0355 in protecting β cells in isolated pancreatic islets and in a murine experimental model of type 1 diabetes. Experimental & Molecular Medicine 2013, 45:e51.
5. Bird T.A., Schooley K., Dower S.K., Hagen H., Virca G.D. Activation of nuclear transcription factor NF-κB by interleukin-1 is accompanied by casein kinase II-mediated phosphorylation of the p65 subunit. Journal of Biological Chemistry 1997, 272:32606-32612.
6. Buchalter L. Isolation and identification of emodin (1,3,8-tri-hydroxy-6-methyl anthraquinone) from Rumex hymenosepalus, family polygonaceae. Journal of Pharmaceutical Sciences 1969, 58:904.
7. Cardozo A.K., Proost P., Gysemans C., Chen M.C., Mathieu C., Eizirik D.L. IL-1β and IFN-γ induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre-diabetic NOD mice. Diabetologia 2003, 46:255-266.
8. Chang I., Kim S., Kim J.Y., Cho N., Kim Y.H., Kim H.S., Lee M.K., Kim K.W., Lee M.S. Nuclear factor κB protects pancreatic β-cells from tumor necrosis factor-α-mediated apoptosis. Diabetes 2003, 52:1169-1175.
9. Chen Z., Zhang L., Yi J., Yang Z., Zhang Z., Li Z. Promotion of adiponectin multimerization by emodin: A novel AMPK activator with PPARγ-agonist activity. Journal of Cell Biochemistry 2012, 113:3547-3558.
10. Choi S.B., Ko B.S., Park S.K., Jang J.S., Park S. Insulin sensitizing and α-glucoamylase inhibitory action of sennosides, rheins and rhaponticin in Rhei Rhizoma. Life Sciences 2006, 78:934-942.
11. Cnop M., Welsh N., Jonas J.C., Jorns A., Lenzen S., Eizirik D.L. Mechanisms of pancreatic β-cell death in type 1 and type 2 diabetes: Many differences, few similarities. Diabetes 2005, 54:S97-S107.
12. Collier J.J., Fueger P.T., Hohmeier H.E., Newgard C.B. Pro- and antiapoptotic proteins regulate apoptosis but do not protect against cytokine-mediated cytotoxicity in rat islets and β-cell lines. Diabetes 2006, 55:1398-1406.
13. Contreras J.L., Bilbao G., Smyth C.A., Jiang X.L., Eckhoff D.E., Jenkins S.M., Thomas F.T., Curiel D.T., Thomas J.M. Cytoprotection of pancreatic islets before and soon after transplantation by gene transfer of the anti-apoptotic Bcl-2 gene. Transplantation 2001, 71:1015-1023.
14. Corbett J.A., McDaniel M.L. Does nitric oxide mediate autoimmune destruction of β-cells? Possible therapeutic interventions in IDDM. Diabetes 1992, 41:897-903.
15. Darville M.I., Eizirik D.L. Cytokine induction of Fas gene expression in insulin-producing cells requires the transcription factors NF-κB and C/EBP. Diabetes 2001, 50:1741-1748.
16. Eizirik D.L., Colli M.L., Ortis F. The role of inflammation in insulitis and β-cell loss in type 1 diabetes. Nature Reviews Endocrinology 2009, 5:219-226.
17. Eizirik D.L., Flodstrom M., Karlsen A.E., Welsh N. The harmony of the spheres: Inducible nitric oxide synthase and related genes in pancreatic β cells. Diabetologia 1996, 39:875-890.
18. Eldor R., Yeffet A., Baum K., Doviner V., Amar D., Ben-Neriah Y., Christofori G., Peled A., Carel J.C., Boitard C., Klein T., Serup P., Eizirik D.L., Melloul D. Conditional and specific NF-κB blockade protects pancreatic β cells from diabetogenic agents. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:5072-5077.
19. Emamaullee J.A., Davis J., Pawlick R., Toso C., Merani S., Cai S.X., Tseng B., Shapiro A.M. The caspase selective inhibitor EP1013 augments human islet graft function and longevity in marginal mass islet transplantation in mice. Diabetes 2008, 57:1556-1566.
20. Emamaullee J.A., Rajotte R.V., Liston P., Korneluk R.G., Lakey J.R., Shapiro A.M., Elliott J.F. XIAP overexpression in human islets prevents early posttransplant apoptosis and reduces the islet mass needed to treat diabetes. Diabetes 2005, 54:2541-2548.
21. Emamaullee J.A., Stanton L., Schur C., Shapiro A.M. Caspase inhibitor therapy enhances marginal mass islet graft survival and preserves long-term function in islet transplantation. Diabetes 2007, 56:1289-1298.
22. Fehsel K., Kolb-Bachofen V., Kroncke K.D. Necrosis is the predominant type of islet cell death during development of insulin-dependent diabetes mellitus in BB rats. Laboratory Investigation 2003, 83:549-559.
23. Goto H., Shimada Y., Tanikawa K., Sato S., Hikiami H., Sekiya N., Terasawa K. Clinical evaluation of the effect of daio (Rhei rhizoma) on the progression of diabetic nephropathy with overt proteinuria. American Journal of Chinese Medicine 2003, 31:267-275.
24. Grey S.T., Longo C., Shukri T., Patel V.I., Csizmadia E., Daniel S., Arvelo M.B., Tchipashvili V., Ferran C. Genetic engineering of a suboptimal islet graft with A20 preserves β cell mass and function. Journal of Immunology 2003, 170:6250-6256.
25. Grunnet L.G., Aikin R., Tonnesen M.F., Paraskevas S., Blaabjerg L., Storling J., Rosenberg L., Billestrup N., Maysinger D., Mandrup-Poulsen T. Proinflammatory cytokines activate the intrinsic apoptotic pathway in β-cells. Diabetes 2009, 58:1807-1815.
26. Gurzov E.N., Germano C.M., Cunha D.A., Ortis F., Vanderwinden J.M., Marchetti P., Zhang L., Eizirik D.L. p53 Up-regulated modulator of apoptosis (PUMA) activation contributes to pancreatic β-cell apoptosis induced by proinflammatory cytokines and endoplasmic reticulum stress. Journal of Biological Chemistry 2010, 285:19910-19920.
27. Heimberg H., Heremans Y., Jobin C., Leemans R., Cardozo A.K., Darville M., Eizirik D.L. Inhibition of cytokine-induced NF-κB activation by adenovirus-mediated expression of a NF-κB super-repressor prevents β-cell apoptosis. Diabetes 2001, 50:2219-2224.
28. Israel A. The IKK complex: An integrator of all signals that activate NF-κB?. Trends in Cell Biology 2000, 10:129-133.
29. Kim E.K., Kwon K.B., Song M.Y., Seo S.W., Park S.J., Ka S.O., Na L., Kim K.A., Ryu D.G., So H.S., Park R., Park J.W., Park B.H. Genistein protects pancreatic β cells against cytokine-mediated toxicity. Molecular and Cellular Endocrinology 2007, 278:18-28.
30. Kim S., Millet I., Kim H.S., Kim J.Y., Han M.S., Lee M.K., Kim K.W., Sherwin R.S., Karin M., Lee M.S. NF-κB prevents β cell death and autoimmune diabetes in NOD mice. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:1913-1918.
31. Kuraya D., Watanabe M., Koshizuka Y., Ogura M., Yoshida T., Asahi Y., Kamachi H., Nakamura T., Harashima H., Ozaki M., Umezawa K., Matsushita M., Yamashita K., Todo S. Efficacy of DHMEQ, a NF-κB inhibitor, in islet transplantation: I. HMGB1 suppression by DHMEQ prevents early islet graft damage. Transplantation 2013, 96:445-453.
32. Kwon N.S., Lee S.H., Choi C.S., Kho T., Lee H.S. Nitric oxide generation from streptozotocin. FASEB Journal 1994, 8:529-533.
33. Lee J.H., Song M.Y., Song E.K., Kim E.K., Moon W.S., Han M.K., Park J.W., Kwon K.B., Park B.H. Overexpression of SIRT1 protects pancreatic β-cells against cytokine toxicity by suppressing the nuclear factor-κB signaling pathway. Diabetes 2009, 58:344-351.
34. Lv N., Song M.Y., Kim E.K., Park J.W., Kwon K.B., Park B.H. Guggulsterone, a plant sterol, inhibits NF-κB activation and protects pancreatic β cells from cytokine toxicity. Molecular and Cellular Endocrinology 2008, 289:49-59.
35. Mabley J.G., Hasko G., Liaudet L., Soriano F.G., Southan G.J., Salzman A.L., Szabo C. NFκB1 (p50)-deficient mice are not susceptible to multiple low-dose streptozotocin-induced diabetes. Journal of Endocrinology 2002, 173:457-464.
36. Marazza J.A., LeBlanc J.G., de Giori G.S., Garro M.S. Soymilk fermented with Lactobacillus rhamnosus CRL981 ameliorates hyperglycemia, lipid profiles and increases antioxidant enzyme activities in diabetic mice. Journal of Functonal Foods 2013, 5(4):1848-1853.
37. May M.J., Ghosh S. Signal transduction through NF-κB. Immunology Today 1998, 19:80-88.
38. Park E., Lee S.M., Kim J.H. Anti-inflammatory activity of mulberry leaf extract through inhibition of NF-κB. Journal of Functional Foods 2013, 5(1):178-186.
39. Rink J.S., Chen X., Zhang X., Kaufman D.B. Conditional and specific inhibition of NF-κB in mouse pancreatic β cells prevents cytokine-induced deleterious effects and improves islet survival posttransplant. Surgery 2012, 151:330-339.
40. Schwarz E.M., Van Antwerp D., Verma I.M. Constitutive phosphorylation of IκBα by casein kinase II occurs preferentially at serine 293: Requirement for degradation of free IκBα. Molecular and Cellular Biology 1996, 16:3554-3559.
41. Sharma R., Tiku A.B. Emodin, an anthraquinone derivative, protects against γ radiation-induced toxicity by inhibiting DNA damage and oxidative stress. International Journal of Radiation Biology 2014, 90:275-283.
42. Shrimali D., Shanmugam M.K., Kumar A.P., Zhang J., Tan B.K., Ahn K.S., Sethi G. Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancer. Cancer Letters 2013, 341:139-149.
43. Song M.Y., Bae U.J., Jang K.Y., Park B.H. Transplantation of betacellulin-transduced islets improves glucose intolerance in diabetic mice. Experimental & Molecular Medicine 2014, 46:e98.
44. Song M.Y., Jeong G.S., Kwon K.B., Ka S.O., Jang H.Y., Park J.W., Kim Y.C., Park B.H. Sulfuretin protects against cytokine-induced β-cell damage and prevents streptozotocin-induced diabetes. Experimental & Molecular Medicine 2010, 42:628-638.
45. Song M.Y., Kim E.K., Moon W.S., Park J.W., Kim H.J., So H.S., Park R., Kwon K.B., Park B.H. Sulforaphane protects against cytokine- and streptozotocin-induced β-cell damage by suppressing the NF-κB pathway. Toxicology and Applied Pharmacology 2009, 235:57-67.
46. Sorli C.H., Zhang H.J., Armstrong M.B., Rajotte R.V., Maclouf J., Robertson R.P. Basal expression of cyclooxygenase-2 and nuclear factor-interleukin 6 are dominant and coordinately regulated by interleukin 1 in the pancreatic islet. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:1788-1793.
47. 2 as mediator for DNA fragmentation. Diabetes 1991, 40:1141-1145.
48. Waly M.I., Ali B.H., Al-Lawati I., Nemmar A. Protective effects of emodin against cisplatin-induced oxidative stress in cultured human kidney (HEK 293) cells. Journal of Applied Toxicology 2013, 33:626-630.